rs886044289
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The ENST00000640872.1(PAX6):c.-357G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
ENST00000640872.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Publications
- aniridia 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- PAX6-related ocular dysgenesisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Peters anomalyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- coloboma, ocular, autosomal dominantInheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- diabetes mellitusInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- aniridia-cerebellar ataxia-intellectual disability syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- foveal hypoplasia-presenile cataract syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated aniridiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated optic nerve hypoplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal dominant keratitisInheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000640872.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PAX6 | NM_001368894.2 | MANE Select | c.52G>T | p.Gly18Trp | missense | Exon 5 of 14 | NP_001355823.1 | ||
| PAX6 | NM_001368929.2 | c.-399G>T | 5_prime_UTR_premature_start_codon_gain | Exon 1 of 9 | NP_001355858.1 | ||||
| PAX6 | NM_001310160.2 | c.-730G>T | 5_prime_UTR_premature_start_codon_gain | Exon 1 of 10 | NP_001297089.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PAX6 | ENST00000640872.1 | TSL:1 | c.-357G>T | 5_prime_UTR_premature_start_codon_gain | Exon 1 of 9 | ENSP00000491065.1 | |||
| PAX6 | ENST00000640368.2 | TSL:5 MANE Select | c.52G>T | p.Gly18Trp | missense | Exon 5 of 14 | ENSP00000492024.1 | ||
| PAX6 | ENST00000419022.6 | TSL:1 | c.52G>T | p.Gly18Trp | missense | Exon 5 of 14 | ENSP00000404100.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Aniridia 1;C0344559:Irido-corneo-trabecular dysgenesis Pathogenic:1
Experimental studies have shown that this missense change affects PAX6 function (PMID: 14744876, 15020706, 24623969). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly18 amino acid residue in PAX6. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15579687, 20577777; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAX6 protein function. This missense change has been observed in individual(s) with PAX6-related conditions (PMID: 9792406). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 18 of the PAX6 protein (p.Gly18Trp).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at